レトロウイルス検査:医療機器パイプライン分析2020

◆英語タイトル:Retrovirus Tests - Medical Devices Pipeline Assessment, 2020

GlobalDataが発行した調査報告書(GD21MC029)◆商品コード:GD21MC029
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年11月30日
◆ページ数:140
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,776,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Retrovirus Tests – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Retrovirus Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Retrovirus Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Retrovirus Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Retrovirus Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

❖ レポートの目次 ❖

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Retrovirus Tests Overview
3 Products under Development
3.1 Retrovirus Tests – Pipeline Products by Stage of Development
3.2 Retrovirus Tests – Pipeline Products by Territory
3.3 Retrovirus Tests – Pipeline Products by Regulatory Path
3.4 Retrovirus Tests – Pipeline Products by Estimated Approval Date
4 Retrovirus Tests – Pipeline Products under Development by Companies
4.1 Retrovirus Tests Companies – Pipeline Products by Stage of Development
4.2 Retrovirus Tests – Pipeline Products by Stage of Development
5 Retrovirus Tests Companies and Product Overview
6 Retrovirus Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Retrovirus Tests - Pipeline Products by Stage of Development
Table 2: Retrovirus Tests - Pipeline Products by Territory
Table 3: Retrovirus Tests - Pipeline Products by Regulatory Path
Table 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date
Table 5: Retrovirus Tests Companies - Pipeline Products by Stage of Development
Table 6: Retrovirus Tests - Pipeline Products by Stage of Development
Table 7: Accelevir Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Diagnostic Test - Latent HIV-1 Virus - Product Status
Table 9: Diagnostic Test - Latent HIV-1 Virus - Product Description
Table 10: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Portable Benchtop Analyzer - Viral Load Assay - Product Status
Table 12: Portable Benchtop Analyzer - Viral Load Assay - Product Description
Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AIMS System - HIV-1 Test - Product Status
Table 15: AIMS System - HIV-1 Test - Product Description
Table 16: AtheNA Multi-Lyte System - HIV-1 Test - Product Status
Table 17: AtheNA Multi-Lyte System - HIV-1 Test - Product Description
Table 18: Allied Innovative Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: HIV p24 Antigen ELISA - Product Status
Table 20: HIV p24 Antigen ELISA - Product Description
Table 21: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Viral Protein Antibody Test - Non-HIV AIDS - Product Status
Table 23: Viral Protein Antibody Test - Non-HIV AIDS - Product Description
Table 24: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 25: DETECTHIV - Product Status
Table 26: DETECTHIV - Product Description
Table 27: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 28: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Status
Table 29: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Description
Table 30: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Diagnostic Test - HIV - Product Status
Table 32: Diagnostic Test - HIV - Product Description
Table 33: IOBS - HIV Diagnostic Test - Product Status
Table 34: IOBS - HIV Diagnostic Test - Product Description
Table 35: Blackfly Investments LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Molecular RNA Test - HIV - Product Status
Table 37: Molecular RNA Test - HIV - Product Description
Table 38: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Second Generation Incidence Test - HIV - Product Status
Table 40: Second Generation Incidence Test - HIV - Product Description
Table 41: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Diagnostic Test - HIV - Product Status
Table 43: Diagnostic Test - HIV - Product Description
Table 44: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: CD4 Assay - HIV - Product Status
Table 46: CD4 Assay - HIV - Product Description
Table 47: Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: HIV RNA Real-time PCR Kit - Product Status
Table 49: HIV RNA Real-time PCR Kit - Product Description
Table 50: Conrad Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Biomarker - HIV Acquisition - Product Status
Table 52: Biomarker - HIV Acquisition - Product Description
Table 53: Biomarker - Hormonal Contraception - Product Status

List of Figures
Figure 1: Retrovirus Tests - Pipeline Products by Stage of Development
Figure 2: Retrovirus Tests - Pipeline Products by Territory
Figure 3: Retrovirus Tests - Pipeline Products by Regulatory Path
Figure 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ レトロウイルス検査:医療機器パイプライン分析2020(Retrovirus Tests - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆